|
|
|
|
|
|
|
3D Screen Printing Powers Next-Gen Complex Formulations
|
|
|
In the past, 3D-printed pharmaceuticals were largely relegated to niche markets and prototyping due to limited scalability and a reliance on manufacturing processes that could potentially damage active pharmaceutical ingredients. However, a new technology — 3D screen printing — is shattering preconceptions and opening new frontiers in drug formulation and manufacture.
|
|
|
|
|
|
|
Steven Facer of Adare Pharma Solutions discusses how CDMOs can build successful partnerships through integration, flexibility, innovation, and a strong customer-first culture in a complex landscape.
|
|
|
|
|
Adare Pharma Solutions provides end-to-end CDMO services for oral solid dose drugs, enabling efficient development, manufacturing, and packaging with advanced technologies and global scale.
|
|
|
|
|
Combining POWDOSE® and Diffucaps® enables precise, individualized solid oral dosing — improving drug delivery, patient compliance, and therapeutic outcomes in personalized medicine applications.
|
|
|
|
|
|
|
|
|
|
|
